Universal screening programme for cytomegalovirus infection in the first trimester of pregnancy: study protocol for an observational multicentre study in the area of Barcelona (CITEMB study).


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
19 07 2023
Historique:
medline: 24 7 2023
pubmed: 21 7 2023
entrez: 20 7 2023
Statut: epublish

Résumé

Congenital cytomegalovirus (cCMV) is the leading cause of non-genetic sensorineural hearing loss and one of the main causes of neurological disability. Despite this, no universal screening programme for cCMV has been implemented in Spain. A recent study has shown that early treatment with valaciclovir, initiated in the first trimester and before the onset of signs in the fetus, reduces the risk of fetal infection. This finding favours the implementation of a universal screening programme for cCMV.The aim of this study is to evaluate the performance of a universal screening programme for cCMV during the first trimester of pregnancy in a primary care setting. This is an observational multicentre cohort study. The study will be conducted in four primary care settings from the Northern Metropolitan Barcelona area and three related hospitals and will last 3 years and will consist of a recruitment period of 18 months.In their first pregnancy visit, pregnant women will be offered to add a CMV serology test to the first trimester screening tests. Pregnant women with primary infection will be referred to the reference hospital, where they will continue treatment and follow-up according to the clinical protocol of the referral hospital, which includes treatment with valacyclovir. A CMV-PCR will be performed at birth on newborns of mothers with primary infection, and those who are infected will undergo neonatal follow-up for at least 12 months of life.For the analysis, the acceptance rate, the prevalence of primary CMV infections and the CMV seroprevalence in the first trimester of pregnancy will be studied. Ethical approval was obtained from the University Institute Foundation for Primary Health Care Research Jordi Gol i Gurina Ethics Committee 22/097-P dated 27 April 2022.

Identifiants

pubmed: 37474185
pii: bmjopen-2023-071997
doi: 10.1136/bmjopen-2023-071997
pmc: PMC10357649
doi:

Substances chimiques

Valacyclovir MZ1IW7Q79D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e071997

Investigateurs

Rocio Rodriguez López (RR)
Margarita Mendoza Ariza (MM)
Meritxell Fors Andreu (MF)
Carolina Exposito Moreno (CE)
Cristina Garcia López (CG)
Elena Scazzocchio Dueñas (ES)
Irene Fernández Torm (IF)
Loida Lucas Porras (LL)
Sara Albero Jiménez (SA)
Julia Arquillos Jiménez (JA)
Alicia Capel Tatjer (AC)
Irene Domínguez García (ID)
Yolanda Reyes Nef (YR)
Asun Teva Calahorro (AT)
Montse Ortiz González (MO)
Esther Rebull López (ER)
Rocío Garrido Carreño (RG)
Sandra Olivera Lindez (SO)
Olga Gracia Salazar (OG)
Marta Calveiro Hermo (MC)
Jordina Munros Feliu (JM)
Astrid Francesch Campi (AF)
Laia Alcoverro Bedos (LA)
Juliana Esperalba (J)
Carlota Rodó (C)
Teresa Higueras Sanz (TH)
Elida Vázquez (E)
Gema Fernandez Rivas (GF)
Ana Sancho Cerro (AS)
Marta López (M)
Karen Castillo-Viteri (K)
Giorgia Sebastiani (G)
Claudia Fortuny (C)
María Rosa Escriche Marco (MR)
Maria Pilar Sancho Perez (MP)
Ana Barluenga Perez-Cossio (AB)
Lucia Alcaraz Vidal (LA)
Cristina Morote Muñoz (CM)
Esther Cerro Hernandez (EC)
Marina Raja Carcaña (MR)
Marta Xiville Sole (MX)
Mercedes Rey Arijón (MR)
Miriam Garcia Sanchez (MG)
Mª Teresa Sanchez Casado (MT)
Natalia Dueñas Herrero (ND)
Paula Amoros Ferrer (PA)
Pilar Cabrerizo Las Heras (PCL)
Raquel Martinez Mondejar (RM)
Cristina Del Viso Lajara (CDV)
Maria Mercedes Vicente Fernández (MMV)
Raquel Antón da Silva (RAD)
Núria Tosquella Roig (NT)
Berta Serrano Ejarque (BS)
Júlia Mitjans Carrasco (JM)
Silvia Martinez Rubiño (SM)
Gemma Prieto Sanchez (GP)

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Am J Obstet Gynecol. 2020 Dec;223(6):870-883.e11
pubmed: 32460972
N Engl J Med. 2021 Jul 29;385(5):436-444
pubmed: 34320288
BJOG. 2022 Jan;129(2):301-312
pubmed: 34651405
Rev Med Virol. 2010 Jul;20(4):202-13
pubmed: 20564615
Eur J Obstet Gynecol Reprod Biol. 2021 Mar;258:409-413
pubmed: 33548895
Am J Obstet Gynecol. 2020 Sep;223(3):330-349
pubmed: 32105678
Rev Med Virol. 2019 May;29(3):e2034
pubmed: 30706584
J Clin Virol. 2012 Feb;53(2):167-70
pubmed: 22177273
Otolaryngol Head Neck Surg. 2023 Mar 8;:
pubmed: 36884018
Ultrasound Obstet Gynecol. 2023 Apr;61(4):436-444
pubmed: 36484439
JAMA. 2010 Aug 25;304(8):859-66
pubmed: 20736469
Pathogens. 2019 Oct 31;8(4):
pubmed: 31683687
J Clin Virol. 2006 Feb;35(2):221-5
pubmed: 16384744
JAMA Pediatr. 2016 Dec 1;170(12):1173-1180
pubmed: 27723885
J Clin Virol. 2020 Jun;127:104351
pubmed: 32325395
J Clin Virol. 2011 Nov;52(3):244-6
pubmed: 21820954
Rev Chilena Infectol. 2021 Dec;38(6):824-856
pubmed: 35506860
Am J Perinatol. 2019 Jun;36(7):678-687
pubmed: 30567003
Arch Dis Child. 2019 Jun;104(6):559-563
pubmed: 30472664
Am J Obstet Gynecol. 2016 Sep;215(3):342.e1-9
pubmed: 27063062
J Pediatr. 2017 Feb;181:267-271.e1
pubmed: 27816221
J Pediatr. 2013 Mar;162(3):593-9
pubmed: 23022111
Pediatr Infect Dis J. 2020 Nov;39(11):1050-1056
pubmed: 32773658
Pediatrics. 2014 Nov;134(5):972-82
pubmed: 25349318
Birth Defects Res A Clin Mol Teratol. 2004 Apr;70(4):201-7
pubmed: 15108247
J Clin Virol. 2009 Dec;46 Suppl 4:S27-31
pubmed: 19836301
Clin Infect Dis. 2019 Oct 15;69(9):1526-1532
pubmed: 30596974
EBioMedicine. 2015 Aug 06;2(9):1205-10
pubmed: 26501119
J Clin Virol. 2011 Apr;50(4):303-7
pubmed: 21277825
Antiviral Res. 2001 Feb;49(2):55-74
pubmed: 11248359
Lancet. 2020 Sep 12;396(10253):779-785
pubmed: 32919517
Arch Dis Child. 2018 May;103(5):452-457
pubmed: 29363491
Clin Microbiol Rev. 2013 Jan;26(1):86-102
pubmed: 23297260
PLoS One. 2019 Aug 26;14(8):e0221725
pubmed: 31449545
N Engl J Med. 2014 Apr 3;370(14):1316-26
pubmed: 24693891
N Engl J Med. 2005 Sep 29;353(13):1350-62
pubmed: 16192480
Infect Dis Obstet Gynecol. 2011;2011:1-9
pubmed: 21836812
Pediatr Rev. 2012 Apr;33(4):156-63; quiz 163
pubmed: 22474112

Auteurs

Maria Angeles Sanchez-Durán (MA)

Maternal Fetal Medicine Unit, Department of Obstetrics; Universitat Autònoma de Barcelona, Hospital Vall d'Hebron, Barcelona, Spain.

Nerea Maiz (N)

Maternal Fetal Medicine Unit, Department of Obstetrics; Universitat Autònoma de Barcelona, Hospital Vall d'Hebron, Barcelona, Spain lliutskop.mn.ics@gencat.cat nerea.maiz@vallhebron.cat.

Liudmila Liutsko (L)

Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol, Mataró, Spain lliutskop.mn.ics@gencat.cat nerea.maiz@vallhebron.cat.
Area Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.

Jofre Bielsa-Pascual (J)

Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol, Mataró, Spain.

Rosa García-Sierra (R)

Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol, Mataró, Spain.
Multidisciplinary Research Group in Health and Society (GREMSAS) (2017-SGR-917), Barcelona, Spain.

Aneta Monika Zientalska (AM)

Service of Obstetrics and Gynecology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Inés Velasco (I)

Service of Obstetrics and Gynecology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Eva Vazquez (E)

Atencio a la Salut Sexual i Reproductiva (ASSIR) Esquerra, Institut Català de la Salut, Barcelona, Spain.

Olga Gracia (O)

Atencio a la Salut Sexual i Reproductiva (ASSIR) Muntanya, Institut Català de la Salut, Barcelona, Spain.

Aleida Ribas (A)

Atencio a la Salut Sexual i Reproductiva (ASSIR) St. Adrià de Besòs, Servei d'Atenció Primària Barcelonès Nord i Maresme, Institut Català de la Salut, Barcelona, Spain.

Nuria Sitja (N)

Atencio a la Salut Sexual i Reproductiva (ASSIR) Santa Coloma de Gramenet, Atenció Primària Metropolitana Nord, Institut Català de la Salut, Santa Coloma de Gramenet, Spain.

Maria Nadales (M)

Atencio a la Salut Sexual i Reproductiva (ASSIR) Badalona, Institut Català de la Salut, Badalona, Barcelona, Spain.

Cristina Martinez (C)

Atencio a la Salut Sexual i Reproductiva (ASSIR) Catalunya, Institut Català de la Salut, Barcelona, Spain.
Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.

Anna Gonce (A)

Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.
BCNatal: Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Hospital Clinic de Barcelona, Barcelona, Spain.

Marie Antoinette Frick (MA)

Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Vall d'Hebron, Barcelona, Spain.

Mercedes Guerrero-Martínez (M)

Atencio a la Salut Sexual i Reproductiva (ASSIR) Santa Coloma de Gramenet, Atenció Primària Metropolitana Nord, Institut Català de la Salut, Santa Coloma de Gramenet, Spain.
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, IDIAP Jordi Gol, Barcelona, Spain.

Concepción Violán (C)

Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol, Mataró, Spain.
Foundation Institute of Research in Health Sciences Germans Trias i Pujol, Badalona, Spain.

Pere Torán (P)

Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol, Mataró, Spain.
Foundation Institute of Research in Health Sciences Germans Trias i Pujol, Badalona, Spain.

Gemma Falguera-Puig (G)

Atencio a la Salut Sexual i Reproductiva (ASSIR) Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.
GRASSIR, Grup preconsolidat en Recerca en Atenció a la Salut Sexual i Reproductiva. IDIAP i AGAUR, IDIAP Jordi Gol, Barcelona, Spain.

Roser Gol (R)

Atencio a la Salut Sexual i Reproductiva (ASSIR) Badalona, Institut Català de la Salut, Badalona, Barcelona, Spain.
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, IDIAP Jordi Gol, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH